Montserrat Colilla

Dr. Montserrat Colilla

Universidad Complutense de Madrid. Dpto. Química en Ciencias Farmacéuticas
+1
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2003 in Chemistry of Materials
Verified
Journal Article
Closed access
MDMargarita Darder
Margarita Darder
Montserrat ColillaMontserrat Colilla
Montserrat Colilla
EREduardo Ruiz-Hitzky
Eduardo Ruiz-Hitzky

1 June 2022 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
María Vallet-RegíMaría Vallet-Regí
María Vallet-Regí
FSFerdi Schüth
Ferdi Schüth
DLDaniel Lozano
Daniel Lozano
Montserrat ColillaMontserrat Colilla
Montserrat Colilla
MMMiguel Manzano
Miguel Manzano
This review details the huge progress in the design and development of mesoporous silica nanoparticles for biomedical applications during the last two decades.

25 December 2017 in Molecules
Verified
Journal Article
Open access
PDF file
María Vallet-RegíMaría Vallet-Regí
María Vallet-Regí
Montserrat ColillaMontserrat Colilla
Montserrat Colilla
Isabel Izquierdo-BarbaIsabel Izquierdo-Barba
Isabel Izquierdo-Barba
MMMiguel Manzano
Miguel Manzano
This manuscript reviews the recent progress on mesoporous silica nanoparticles as drug delivery systems. Their intrinsic structural, textural and chemical features permit to design versatile multifunctional nanosystems with the capability to target the diseased tissue and release the cargo on demand upon exposition to internal or external stimuli. The degradation rate of these nanocarriers in diverse physiological fluids is overviewed obeying their significance for their potential translation towards clinical applications. To conclude, the balance between the benefits and downsides of this revolutionary nanotechnological tool is also discussed.

1 March 2008 in Chemical Engineering Journal
Verified
Journal Article
Closed access
MMM. Manzano
M. Manzano
VAV. Aina
V. Aina
CAC.O. Areán
C.O. Areán
FBFrancisco Balas
Francisco Balas
VCValentina Cauda
Valentina Cauda
María Vallet-RegíMaría Vallet-Regí
María Vallet-Regí

4 November 2010 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
María Vallet-RegíMaría Vallet-Regí
María Vallet-Regí
Montserrat ColillaMontserrat Colilla
Montserrat Colilla
BGBlanca González
Blanca González
Research on bioceramics has evolved from the use of inert materials for mere substitution of living tissues towards the development of third-generation bioceramics aimed at inducing bone tissue regeneration. Within this context hybrid bioceramics have remarkable features resulting from the synergistic combination of both inorganic and organic components that make them suitable for a wide range of medical applications. Certain bioceramics, such as ordered mesoporous silicas, can exhibit different kind of interaction with organic molecules to develop different functions. The weak interaction of these host matrixes with drug molecules confined in the mesoporous channels allows these hybrid systems to be used as controlled delivery devices. Moreover, mesoporous silicas can be used to fabricate three (3D)-dimensional scaffolds for bone tissue engineering. In this last case, different osteoinductive agents (peptides, hormones and growth factors) can be strongly grafted to the bioceramic matrix to act as attracting signals for bone cells to promote bone regeneration process. Finally, recent research examples of organic–inorganic hybrid bioceramics, such as stimuli-responsive drug delivery systems and nanosystems for targeting of cancer cells and gene transfection, are also tackled in this tutorial review (64 references).

1 January 2005 in Applied Clay Science
Verified
Journal Article
Closed access
MDMargarita Darder
Margarita Darder
Montserrat ColillaMontserrat Colilla
Montserrat Colilla
EREduardo Ruiz-Hitzky
Eduardo Ruiz-Hitzky